Key facts
- A new meta-study from the University of Georgia compared the effectiveness of three GLP-1 medications for weight loss.
- The study analyzed 14,000 non-diabetic patients and found tirzepatide to be the most effective.
- Patients taking tirzepatide (Zepbound/Mounjaro) lost over 20% of their starting weight.
- Semaglutide (Wegovy/Ozempic) resulted in approximately 15% weight loss.
- Liraglutide (Saxenda/Victoza) led to about 8% weight loss.
A new meta-analysis from the University of Georgia has identified tirzepatide as the most effective GLP-1 medication for weight loss among non-diabetic patients. The study, which examined data from 14,000 individuals, found that tirzepatide, sold under brand names like Zepbound and Mounjaro, led to a loss of over 20% of starting body weight.